Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural response to CBD in healthy females
NCT04777643Phase 1Completed
- Sponsor
- Yale University
- Start
- Jun 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anxiety disorder comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Amygdala activation during stress at 2 hours and Insula activation during social exclusion at 2 hours. Started Jun 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04777643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04777643.